Just look at the valuations US Funds give to NRT another much earlier stage Pre Clinical Oncology company
PTX shouldn't waste it's time with weak Australian investors and brokers that just don't understand the space, they should focus on getting US money interest behind them
Ann: Encouraging Pre-Clinical Data Presented at US Cancer Meeting, page-10
Add PTX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.9¢ |
Change
-0.001(2.50%) |
Mkt cap ! $32.21M | |||
| Open | High | Low | Value | Volume |
| 4.0¢ | 4.0¢ | 3.9¢ | $10.55K | 269.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 757841 | 3.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.9¢ | 647611 | 1 |
View Market Depth
| Last trade - 15.30pm 20/11/2024 (20 minute delay) ? |
| PTX (ASX) Chart |
